Dimethylarginine dimethylaminohydrolase I enhances tumour growth and angiogenesis

Angiogenesis is a prerequisite for tumour progression and is highly regulated by growth factors and cytokines a number of which also stimulate the production of nitric oxide. Asymmetric dimethylarginine is an endogenous inhibitor of nitric oxide synthesis. Asymmetric dimethylarginine is metabolised...

Descripción completa

Detalles Bibliográficos
Autores principales: Kostourou, V, Robinson, S P, Cartwright, J E, Whitley, G St J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2002
Materias:
Experimental Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364234/
https://www.ncbi.nlm.nih.gov/pubmed/12237779
http://dx.doi.org/10.1038/sj.bjc.6600518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364234/
https://www.ncbi.nlm.nih.gov/pubmed/12237779
http://dx.doi.org/10.1038/sj.bjc.6600518

Ejemplares similares